Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABCM | Abcam plc

Index- P/E1879.17 EPS (ttm)0.01 Insider Own6.44% Shs Outstand229.20M Perf Week-0.40%
Market Cap3.46B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float215.25M Perf Month0.04%
Income3.10M PEG5219.91 EPS next Q- Inst Own14.40% Short Float / Ratio0.83% / 0.38 Perf Quarter-1.83%
Sales471.20M P/S7.34 EPS this Y-148.90% Inst Trans21.31% Short Interest1.79M Perf Half Y70.96%
Book/sh3.89 P/B5.80 EPS next Y- ROA0.20% Target Price24.25 Perf Year44.74%
Cash/sh0.64 P/C35.29 EPS next 5Y0.36% ROE0.40% 52W Range12.48 - 25.32 Perf YTD44.92%
Dividend- P/FCF- EPS past 5Y- ROI-0.30% 52W High-10.94% Beta0.91
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin75.90% 52W Low80.69% ATR0.35
Employees1800 Current Ratio1.40 Sales Q/Q35.30% Oper. Margin2.20% RSI (14)46.96 Volatility0.59% 1.38%
OptionableYes Debt/Eq0.30 EPS Q/Q471.20% Profit Margin0.70% Rel Volume2.16 Prev Close22.59
ShortableYes LT Debt/Eq0.12 Earnings- Payout0.00% Avg Volume4.67M Price22.55
Recom3.00 SMA20-0.82% SMA50-1.43% SMA20025.12% Volume10,064,595 Change-0.18%
Date Action Analyst Rating Change Price Target Change
Jun-20-23Downgrade RBC Capital Mkts Outperform → Sector Perform $23 → $22
Jun-16-23Upgrade BofA Securities Neutral → Buy $25
Dec-14-22Initiated Deutsche Bank Hold $15
Nov-16-20Initiated Morgan Stanley Equal-Weight $21
Sep-21-23 03:41PM
Sep-14-23 06:59PM
Aug-31-23 04:15PM
Aug-28-23 07:35AM
09:23AM Loading…
Aug-18-23 09:23AM
Jul-31-23 07:48AM
Jul-25-23 09:40AM
Jul-12-23 09:07AM
Jul-05-23 04:15PM
Jun-28-23 08:45AM
Jun-26-23 04:05PM
Jun-23-23 03:44PM
Jun-22-23 05:00AM
12:00PM Loading…
Jun-21-23 12:00PM
Jun-20-23 02:45PM
Jun-19-23 03:43AM
Jun-16-23 02:21PM
Jun-15-23 12:47PM
May-30-23 04:30PM
May-23-23 09:55AM
May-17-23 09:18AM
May-11-23 11:45AM
May-04-23 04:30PM
May-01-23 06:00PM
07:00AM Loading…
Apr-17-23 07:00AM
Apr-13-23 04:15PM
Mar-30-23 07:00AM
Mar-20-23 07:05AM
Mar-10-23 08:00AM
Jan-30-23 08:00AM
Dec-27-22 04:58PM
Dec-12-22 09:53AM
Nov-16-22 05:09PM
Nov-11-22 10:30AM
Nov-09-22 06:00AM
Oct-17-22 02:00AM
Oct-05-22 09:25AM
Sep-13-22 04:24AM
Sep-12-22 08:00AM
Jul-20-22 09:50AM
Jul-13-22 01:22AM
Jun-27-22 02:00AM
Jun-18-22 04:24AM
May-02-22 05:35AM
Mar-25-22 08:40AM
Mar-18-22 10:00AM
Mar-14-22 08:00AM
Mar-10-22 04:46AM
Feb-01-22 04:00AM
Jan-09-22 01:02AM
Jan-04-22 04:00AM
Nov-09-21 11:16PM
Nov-02-21 08:00AM
Oct-27-21 02:00AM
Sep-13-21 07:00AM
Aug-02-21 07:38AM
Jul-29-21 09:06AM
Jul-13-21 12:44PM
Jun-24-21 08:09PM
Jun-22-21 08:00AM
May-29-21 06:33AM
May-24-21 02:59AM
Apr-12-21 05:00AM
Mar-24-21 07:49AM
Mar-08-21 11:15AM
Mar-04-21 04:00AM
Feb-26-21 02:00AM
Feb-17-21 07:00AM
Jan-28-21 07:08PM
Jan-27-21 08:00AM
Jan-11-21 07:00AM
Dec-08-20 07:00AM
Dec-05-20 08:03PM
Nov-03-20 08:35AM
Oct-26-20 11:45AM
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.